A comparative study of spray-dried and freeze-dried hydrocortisone/ polyvinyl pyrrolidone solid dispersions

Drug Development and Industrial Pharmacy

Volumn 37, Issue 10, 2011, Pages 1141-1149

  Dontireddy, Rakesh ^a   Crean, Abina M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Amorphous; Dissolution; Freeze drying; Poor aqueous solubility; Solid dispersions; Spray drying; Stability

Indexed keywords

HYDROCORTISONE; POVIDONE;

ARTICLE; CRYSTALLIZATION; DISPERSION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; GLASS TRANSITION TEMPERATURE; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; MOISTURE; MOLECULAR INTERACTION; SOLID STATE; SPRAY DRYING;

CALORIMETRY, DIFFERENTIAL SCANNING; DESICCATION; DRUG CARRIERS; FREEZE DRYING; HYDROCORTISONE; PARTICLE SIZE; POVIDONE; POWDERS; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER; X-RAY DIFFRACTION;

EID: 80052475487     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.562213     Document Type: Article

References (30)

1. Lipinski CA. (2000). Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods, 44:235-249 (Pubitemid 32239479)
2. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46:3-26 (Pubitemid 33653411)
3. Corrigan OI, Timoney RF. (1975). The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethiazide. J Pharm Pharmacol, 27:759-764
4. Corrigan OI, Holohan EM. (1984). Amorphous spraydried hydroflumethiazide-polyvinylpyrrolidone systems: physiochemical properties. J Pharm Pharmacol, 36:217-221 (Pubitemid 14164792)
5. Mosharraf M, Nystr C. (1999). The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs. Eur J Pharm Sci, 9:145-156 (Pubitemid 30012071)
6. Panchagnula R, Bhardwaj V. (2008). Effect of amorphous content on dissolution characteristics of rifampicin. Drug Dev Ind Pharm, 34:642-649 (Pubitemid 351878683)
7. Kaushal AM, Gupta P, Bansal AK. (2004). Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst, 21:133-193 (Pubitemid 41647581)
8. Zhang GGZ, Chen Y, Qiu Y. (2009). Crystalline and amorphous solids, in Developing Solid Oral Dosage Forms. Academic Press, San Diego, pp. 25-60
9. Van den Mooter G, Augustijns P, Blaton N, Kinget R. (1998). Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm, 164:67-80 (Pubitemid 28160099)
10. Corrigan OI, Crean AM. (2002). Comparative physicochemical properties of hydrocortisone-PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying. Int J Pharm, 245:75-82 (Pubitemid 35299893)
11. Andrews GP, Zhai H, Tipping S, Jones DS. (2009). Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions. J Pharm Sci, 98:4545-4556
12. Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P et al. (2001). Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci, 12:261-269
13. Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. (2007). Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm, 336:22-34 (Pubitemid 46551551)
14. Betageri GV, Makarla KR. (1995). Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm, 126:155-160 (Pubitemid 26015632)
15. Van den Mooter G, Weuts I, De Ridder T, Blaton N. (2006). Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm, 316: 1-6 (Pubitemid 43765697)
16. van Drooge DJ, Hinrichs WL, Wegman KA, Visser MR, Eissens AC, Frijlink HW. (2004). Solid dispersions based on inulin for the stabilisation and formulation of delta 9-tetrahydrocannabinol. Eur J Pharm Sci, 21:511-518 (Pubitemid 38283925)
17. Pandya P, Gattani S, Jain P, Khirwal L, Surana S. (2008). Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation. AAPS Pharmscitech, 9:1247-1252
18. Franks F. (2008). Freeze-Drying of Pharmaceuticals and Biopharmaceuticals: Principles and Practice. RSC publishing, Cambridge, pp. 72-88
19. Hancock BC, Dalton CR, Pikal MJ, Shamblin SL. (1998). A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials. Pharm Res, 15:762-767 (Pubitemid 28275655)
20. Couchman PR. (1978). Compositional variation of glasstransition temperatures. 2. Application of the thermodynamic theory to compatible polymer blends. Macromolecules, 11:1156-1161
21. Couchman PR, Karasz FE. (1978). A classical thermodynamic discussion of the effect of composition on glass-transition temperatures. Macromolecules, 11:117-119
22. Pinal R. (2008). Entropy of mixing and the glass transition of amorphous mixtures. Entropy, 10:207-223
23. Forster A, Hempenstall J, Rades T. (2003). Comparison of the Gordon-Taylor and Couchman-Karasz equations for prediction of the glass transition temperature of glass solutions of drug and polyvinylpyrrolidone prepared by melt extrusion. Pharmazie, 58:838-839 (Pubitemid 37462471)
24. Tajber L, Corrigan OI, Healy AM. (2005). Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites-analysis of glass transition composition relationships. Eur J Pharm Sci, 24:553-563 (Pubitemid 40387269)
25. Nair R, Nyamweya N, Gien S, Martiez-Miranda LJ, Hoag SW. (2001). Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int J Pharm, 225:83-96 (Pubitemid 32728202)
26. Silverstein RM, Webster FX, Kiemle D. (2005). Spectrometric Identification of Organic Compounds, 7th edition. Wiley, New York
27. Kaushal AM, Chakraborti AK, Bansal AK. (2008). FTIR studies on differential intermolecular association in crystalline and amorphous states of structurally related non-steroidal antiinflammatory drugs. Mol Pharm, 5:937-945
28. Wen H. (2006). Adsorption at solid surfaces: pharmaceutical applications, in Encyclopedia of Pharmaceutical Technology, J., Swarbrick, ed. Informa Healthcare, New York, pp. 34-45
29. Mahlin D, Berggren J, Gelius U, Engstri S, Alderborn G. (2006). The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles. Int J Pharm, 321:78-85 (Pubitemid 44247422)
30. Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17:397-404 (Pubitemid 30395293)